Modus Therapeutics AB
0
0
+SEK0.00+0% 00:00 Today
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Financials
-Profit Margin
Unprofitable0Revenue
-4.65MNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Modus Therapeutics Holding AB (publ), a biotechnology company, develops a treatment for sepsis and septic shock in Sweden. It develops Sevuparin, a lipopolysaccharide in Phase IIa trial to treat patients with sepsis, septic shock, anemia associated with chronic kidney disease, endotoxemia, severe malaria, and other diseases involving severe systemic inflammation. Modus Therapeutics Holding AB (publ) was founded in 2011 and is headquartered in Stockholm, Sweden.
Show More
CEO
John Öhd
Employees
2
Country
Sweden
ISIN
SE0025667546
Listings
0 Comments
Share your thoughts
FAQs
What is Modus Therapeutics AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Stockholm Exchange exchange Modus Therapeutics AB stocks are traded under the ticker MODTX-BT-UN.ST.
What is Modus Therapeutics AB revenue for the last year?▼
Modus Therapeutics AB revenue for the last year amounts to 0 SEK.
What is Modus Therapeutics AB net income for the last year?▼
MODTX-BT-UN.ST net income for the last year is -4.65M SEK.
How many employees does Modus Therapeutics AB have?▼
As of November 3, 2026, the company has 2 employees.
In which sector is Modus Therapeutics AB located?▼
Modus Therapeutics AB operates in the Health & Wellness sector.
When did Modus Therapeutics AB complete a stock split?▼
Modus Therapeutics AB has not had any recent stock splits.
Where is Modus Therapeutics AB headquartered?▼
Modus Therapeutics AB is headquartered in Stockholm, Sweden.